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1. Introduction
  Oxidative stress has been implicated in various 
pathological conditions including cardiovascular diseases, 
cancer and aging[1]. Positive association between the 
consumption of polyphenol-rich foods and beverages and 
the prevention of these conditions has been shown by 
several epidemiological studies[2]. Tea is one of the most 
popular beverages consumed by humans and many different 
types have been shown to contain polyphenols[3-5], which 
are known for their antioxidant properties. Moreover, the 
reducing power of polyphenols associated with other dietary 
antioxidants can protect the body tissues against oxidative 
stress[6-8].
  Phyllanthus niruri (P. niruri, Euphorbiaceae) is a plant 
widely found in Brazil, locally known as quebra-pedra 
(stone crusher) and is popularly used for the treatment 
of renal pathologies, particularly urolithiasis[9,10]. The 
medicinal properties of this plant have been associated with 
some of its active components such as lignans, glycosides, 
alkaloids, ellagitannins, terpenes and phenylpropanoids, 
besides flavonoids and polyphenols, such as quercetin, 
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rutin and gallic acid (GA)[11]. Although many in vitro 
and in vivo antioxidant effects of P. niruri extracts have 
been shown[11-13], which seem to be determined by its 
polyphenolic components[11,14,15], the bioavailability of those 
components and their impact on human health need further 
investigation.
  Recently, we have shown that P. niruri exhibits antioxidant 
effects in in vitro and in vivo models of liver toxicity in 
mice[11]. That raises the possibility that this plant can 
have a broader antioxidant effect in mammals. Therefore, 
considering the presence of GA, one of the most readily-
absorbed polyphenolic compounds from vegetables[15], and 
the lack of studies investigating the effects of P. niruri tea 
ingestion, we focused the current study on determining 
the plasma levels of GA following the ingestion of the 
tea. Additionally, we have also investigated the potential 
antioxidant effects of P. niruri tea ingestion on healthy 
subjects.
2. Materials and methods
2.1. Preparation of P. niruri infusion
  To prepare the infusion, a commercially available brand 
of P. niruri (Prenda®) tea was used. The phytochemical 
composition of the commercial preparation was identical 
to that of a known P. niruri voucher specimen (number 
SMDB 13142 at the UFSM herbarium). The infusion was 
prepared with five packets (5 g) in 750 mL of boiling water. 
The infusion was allowed to cool for 15 min before being 
given to the subjects. The volunteers were then instructed to 
consume the tea within 10 min.
2.2. Participants
  The study protocol n.0034.0.243.000-10 was approved by 
the Human Ethics Committee of the Universidade Federal 
de Santa Maria and informed consent was obtained from all 
of the participants. Five non-smoker, male subjects with no 
history of previous chronic diseases and not under treatment 
for any current chronic or acute diseases (as self declared 
by the volunteers), average age of (27.2±1.5) (range 20 to 
30) years old, average body mass index of (24.5±2.3) (range 
22.8-27.4) kg/m2, were enrolled. Exclusion criteria included 
smoking, high alcohol intake (above 20 g of alcohol/d), 
consumption of vitamins, mineral supplements or the acute 
or chronic use of any other licit or illicit drugs. Each subject 
was tested twice following a randomized crossover design 
regarding the ingestion of the P. niruri tea or the same 
amount of lukewarm water. Fasting venous blood samples 
were collected into 10 mL heparinized syringes at 0 (before 
drinking), 1, 2 and 4 h after either tea or water ingestion. 
Blood samples were always drawn between 8:00 am and 1:00 
pm. The volunteers were instructed by a nutritionist to avoid 
the consumption of flavonoid-rich (apples, grapes and their 
derivatives such as wine and juices), phytate- or tannin-
containing (coffee, tea, chocolate, among others) aliments on 
the day before and during the blood sampling period.
2.3. Sample processing and quantification of GA by HPLC
  The blood samples were stored at -20 曟 for up to 2 months. 
The samples were then thawed on ice and centrifuged for 
1 min at 10 000 r/min at 4 曟. The plasma fractions (1.5 mL) 
were transferred to 15 mL plastic tubes containing 13.5 mL 
of nitrogen-saturated methanol (HPLC grade) and stored 
at -20 曟 for up to 2 months. The tubes were vigorously 
vortexed and then centrifuged at 1 200 r/min for 10 min, at 
4 曟. The supernatants were decanted into glass tubes under 
a stream of nitrogen and the tubes were screw-capped right 
away[16]. The chromatographic analyses were carried out in 
isocratic conditions using a RP-C18 column (4.6 mm × 250.0 
mm) packed with 5 毺m diameter particles. The mobile 
phase consisted of methanol:acetonitrile:water (40:15:45, 
v/v) containing 1% (v/v) acetic acid. Aliquots (20 毺L) of the 
clear methanolic plasma extract were injected and run at 
0.8 mL/min with detection at 254 nm. The mobile phase 
was filtered through a 0.45 毺m membrane filter and then 
degassed by ultrasound immediately before use. Reference 
GA solutions were prepared in the HPLC mobile phase at 
concentrations ranging from 0.006 to 0.250 mg/mL[17-18]. The 
retention times of the peaks from the plasma samples were 
compared to those obtained for the reference GA solutions 
and quantitated by peak integration using the external 
standard method. The calibration curve for GA was y = 
53 985x+1 020.6 (r=0.985 9). All chromatographic procedures 
were performed at room temperature and in triplicate.
2.4. Determination of plasmatic ascorbic acid (AA)
  Plasma AA levels were measured as described by Jacques-
Silva et al[19]. Plasma was precipitated with one volume of 
100 g/L cold trichloroacetic acid solution and centrifuged 
at 3 000 r/min for 5 min at 4 曟. Aliquots (300 毺L) of the 
supernatants were mixed with 2,4-dinitrophenylhydrazine 
(4.5 mg/mL), CuSO4 (0.075 mg/mL) and 133 g/L trichloroacetic 
acid (final volume 1 mL), and incubated for 3 h at 37 曟. 
Then, 1 mL of 65% H2SO4 (v/v) was added to the medium. The 
AA content was calculated using a standard curve (1.5-4.5 毺mol/L
AA freshly prepared in sulfuric acid) and expressed as 毺
mol of AA/mL of plasma.
 Elisângela Colpo et al./Asian Pacific Journal of Tropical Medicine (2014)113-118 115
2.5. Erythrocyte catalase (CAT) activity
  CAT activity was measured by the method of Aebi[20]. 
Packed erythrocytes (10 毺L) were hemolyzed by adding 
100 volumes of distilled water (990 毺L). Then, 20 毺L of the 
hemolysed red blood cells (RBC) were transferred to a 1 mL 
quartz cuvette and the reaction was started by the addition 
of 100 毺L of freshly prepared 300 mmol/L H2O2 in 50 mmol/L 
phosphate buffer (pH 7.0) to a final volume of 1 mL. The rate 
of H2O2 decomposition was measured spectrophotometrically 
at 240 nm for 120 s. CAT activity was expressed as 毺mol 
H2O2/mL packed RBC per minute.
2.6. Erythrocyte superoxide dismutase (SOD)
  SOD activity was assayed spectrophotometrically as 
described by Boveris and Cadenas[21]. This method is 
based on the capacity of SOD to inhibit the autoxidation of 
adrenaline to adrenochrome. Adrenaline autoxidation was 
monitored at 480 nm. One unit of enzyme activity is defined 
as the amount of enzyme required to inhibit the rate of 
epinephrine autoxidation by 50% at 26 曟.
2.7. Determination of ROS by flow cytometry
  Intracellular H2O2 was determined using DCF-DA 
(Sigma Chemical Co.) as described by Hasui et al.[22] with 
modifications. Intracellular peripheral blood mononuclear 
cells DCF-DA fluorescence was determined by flow 
cytometry (FACScalibur analyzer, BD Biosciences). The 
leukocytes were then isolated by mixing total blood with 
lysing solution (BDFacsTM) as indicated by the manufacturer. 
The cells (1×106/mL) were washed twice with PBS (pH 7.4), 
centrifuged at 1 800 r/min for 5 min, and resuspended 
in ice-cold PBS. Cells were then incubated with DCF-
DA (2 毺mol/L final) for 30 min at 37 曟. Excess DCF-
DA was removed by washing the cells once with PBS and 
centrifuging at 1 800 r/min for 5 min. At least 50 000 events 
were counted for each blood sample.
2.8. Statistical analysis
  Data are expressed as mean±standard deviation (SD). 
Statistical analyses were performed using analysis of 
variance (ANOVA), followed by post hoc Duncan’s multiple 
range test. When appropriate, repeated measures (ANOVA) 
were used, followed by post hoc Duncan’s multiple range 
test. Results were considered significant when P<0.05.
3. Results
  GA is a compound found in plants both in a free and in a 
bound form. It is found in large amounts in P. niruri leaves, 
from which it can be extracted by hot water infusions. 
HPLC analysis of the commercial P. niruri tea indicated the 
presence of GA and an unknown related compound as the 
major components. The quantity of GA found in the different 
filtrates (tea) of P. niruri with hot water varied from 55 to 70 
mg/mL (Figure 1). Plasma levels of GA were significantly 
increased at 1, 2 and 4 h after P. niruri ingestion (paired 
comparisons of sample times 1, 2 and 4 h with baseline 
[before ingestion]) showing that GA was rapidly absorbed 
(Figure 2). No significant variation in GA levels, compared 
to baseline levels, was observed among control subjects 
[(1.32±0.15), (1.36±0.11), (1.40±0.11) and (1.36±0.15) 毺mol/L 
at 0, 1, 2 and 4 h, respectively]. The identity of GA in plasma 
was confirmed by the UV-VIS spectra of the corresponding 
standard peak of GA (Figure 3). In order to investigate 
whether these increases in plasma GA are associated 
with antioxidant effects, we determined the plasma AA 
levels, RBC CAT and SOD activities and peripheral blood 
mononuclear cell reactive oxygen species (ROS) formation 
by flow cytometry, before and after the ingestion of P. niruri 
tea.
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Figure 1. Chromatograms of standard gallic acid (A) and P. niruri (B). 
The peak 1 corresponds to gallic acid and the peak 2 is from an 
undetermined compound. Chromatographic conditions are described 
in the experimental section. 
0.15
0.10
0.05
0.00
-0.05
-0.10G
al
li
c 
ac
id
 le
ve
l (
毺
g/
m
L
)
0.15
0.10
0.05
0.00
-0.05
-0.10G
al
li
c 
ac
id
 le
ve
l (
毺
g/
m
L
)
Control P. niruri
*
*
*
1 h-basal     2 h-basal       4 h-basal 1 h-basal     2 h-basal       4 h-basal
Figure 2. Gallic acid levels in plasma after P. niruri ingestion. 
Data are expressed as the differences between each time point minus 
the baseline values for each subject. *P<0.05 compared with that 
before treatment (Wilcoxon test).
  
  P. niruri consistently caused a significant transient 
increase in plasma AA at 1 h [paired comparisons of 1 h vs 
baseline (0 h), P<0.05] (Figure 4). No significant changes in 
plasma AA were detected at none of the tested time points 
among the control subjects (Figure 4). Neither RBC CAT nor 
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SOD (Table 1) activities were altered after P. niruri intake. 
On the other hand, a decrease in DCF-DA fluorescence 
was observed at 2 h after the ingestion of P. niruri tea in 
peripheral blood mononuclear cells (Figure 5).
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Figure 3. Peak marked refers to the increase in the area after 
ingestion of P. niruri tea.
Peak marked (chromatograms after 1, 2 and 4 h post P. niruri 
ingestion) refers to the increase in the area of gallic acid after ingestion 
of P. niruri tea, when compared to the chromatograms after 1, 2 and 4 
h post water ingestion. Peaks are indicated by arrows.
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Figure 4. Plasmatic ascorbic acid after P. niruri ingestion. 
Data are expressed as the differences between each time point minus 
the baseline values for each subject. *P<0.05 compared with that 
before treatment (Wilcoxon test). 
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Figure 5. Reactive oxygen species (ROS) production in (A) 
granulocytes, (B) monocytes and (C) lymphocytes. 
ROS formation was measured by FACS using DCF-DA fluorescence. 
Data are expressed as the differences between each time point minus 
the baseline values for each subject. *P<0.05 compared with that 
before treatment (Wilcoxon test). AUF: Arbitrary units of fluorescence 
intensity. 
4. Discussion
  P. niruri is commonly used in folk medicine to treat renal 
disease, particularly urolithiasis, and there is a clinical 
evidence supporting that P. niruri extracts can be an 
effective adjuvant in the treatment of renal calculus[11,23]. 
Of particular importance, urolithiasis has an inflammatory 
component, which is associated with oxidative stress[24]. 
Here, we detected only a modest antioxidant effect of P. 
niruri tea ingestion in healthy subjects, as indicated by a 
transitory increase in AA and by a sustained increase in 
plasma GA up to 4 h after tea ingestion. This increase might 
be related to the presence of AA in P. niruri extract[25]. 
Accordingly, experimental studies using rodents have 
shown that chronic ingestion of aqueous extracts of P. 
niruri enhances the cellular antioxidant defense system, 
including the levels of vitamin C, glutathione, as well as 
SOD, CAT, and glutathione peroxidase activities[26-27]. In 
contrast to vitamin C, in the present study, the activities of 
antioxidant enzymes (SOD and CAT) were not altered by the 
Table 1
Catalase and SOD activities after P. niruri ingestion.
Treatment time (h)
Catalase (毺mol H2O2/mL erythrocytes per minute)        SOD activity (IU)
Control P. niruri Control P. niruri
0 37.6依2.90 35.7依2.86 56.7依4.11 61.8依1.78
1 35.5依3.50 30.1依4.02 54.9依5.80 63.4依1.60
2 33.5依3.65 30.7依3.34 60.6依2.68 56.3依5.90
4 39.3依4.13 32.7依2.31 60.1依4.12 63.0依1.13
Results are expressed as mean依SD.
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ingestion of P. niruri tea. The absence of alteration in those 
enzymes activities might be related to the fact that P. niruri 
was given as a single dose. Recently, Ferk et al reported 
that supplementation of drinking water with GA in humans 
for 3 d caused a reduction of DNA damage in lymphocytes 
of healthy individuals[28]. That effect was paralleled by an 
increase in the activities of antioxidant enzymes, whereas 
the total antioxidant capacity and malondialdehyde levels 
in serum were not modified. Other studies have shown the 
modest transient increases in plasma antioxidant capacity 
after tea ingestion in humans[29]. Thus, although the plasma 
level of antioxidants can be expected to influence the 
intracellular antioxidant capacity of different cell types[30], 
this direct correlation does not always occur. Taken together, 
these results indicate that an overlap between extra- and 
intra-cellular antioxidant capacity is not always the case.
  Here, we have observed a significant, though modest, 
decrease in DFC-DA fluorescence in monocytes, but no 
significant alteration was detected in granulocytes or 
lymphocytes. Furthermore, RBC SOD and CAT activities 
were not altered by P. niruri ingestion. Therefore, the 
modulation of antioxidant markers in all of these cell types 
is not concordant, which is in agreement with some previous 
studies[31-33]. 
  Little is known about the absorption and metabolism 
of hydroxybenzoic acids like GA. The fact that just a few 
nutritional sources of GA are known and have resulted in 
limited interest by nutritionists. However, a few studies 
addressing the bioavailability of GA in humans have 
revealed that this compound is more absorbed than other 
polyphenols, though with a short mean half-live of about 
1 h, indicating a very rapid elimination[15,34]. Our current 
results are similar to those obtained by Shahrzad et al, who 
found an increase in blood GA after ingestion of black tea in 
healthy humans[34]. In this study, plasma GA concentration 
increased from 1.3 to 1.6 毺mol/L after ingestion of a large 
volume of P. niruri tea. As mentioned above, those levels of 
GA are within the same concentration range as previously 
reported (1.8-2.6 毺mol/L) and vary depending on the 
volume, blood sampling time and formulation ingested[34,35]. 
This may indicate that part of the modest antioxidant effect 
observed herein might be associated with GA and related 
substances. However, here GA was determined by HPLC, 
and although the UV-VIS spectra of the plasmatic GA peak 
is coincident with that of pure GA, further studies with more 
accurate analytical methods should be performed to confirm 
the increase in plasmatic GA after ingestion of P. niruri tea. 
Another limitation of the present study is that only GA was 
quantified, despite the fact that P. niruri extract contain a 
variety of polyphenolic compounds. Unfortunately, the other 
two peaks detected in the P. niruri infusion, which had 
similar spectra and retention time compared to those found 
in plasma, could not be identified and quantitated due to the 
lack of suitable standards.
  Here, it is shown an increase of GA in plasma following 
the ingestion (1 to 4 h) of P. niruri tea. Furthermore, we have 
observed a transient increase in plasma AA levels within 
the 1st hour after the tea ingestion, which may be associated 
with an increase in circulating GA. Therefore, P. niruri tea 
ingestion seems to be associated with a modest increase in 
antioxidant markers in human plasma. However, further 
studies are required to determine the effects of chronic 
ingestion of P. niruri and its potential as an antioxidant 
modulator of peripheral blood oxidative stress in healthy 
human subjects and whether or not this can be involved in 
the therapeutic effects of this plant.
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